Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1062 | 984 | 1248 | 829 | 1333 | - |
Fund Return | 6.19% | -1.61% | 24.84% | -6.05% | 5.91% | - |
Place in category | 31 | 44 | 43 | 54 | 16 | - |
% in Category | 22 | 35 | 35 | 45 | 20 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
T. Rowe Price Capital Appreciation | 34.97B | 11.29 | 5.66 | 10.62 | ||
T. Rowe Price Blue Chip Growth | 31.42B | 28.40 | 5.04 | 14.38 | ||
T. Rowe Price Capital AppreciationI | 29.37B | 11.42 | 5.79 | - | ||
T. Rowe Price Blue Chip Growth I | 29.8B | 28.53 | 5.18 | - | ||
T. Rowe Price Instl Large Cap Growt | 22.67B | 24.63 | 5.87 | 15.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFS International New Discovery R6 | 4.82B | 5.60 | -1.25 | 5.30 | ||
Fidelity Series International Sm C | 3.93B | 5.19 | -2.58 | 7.60 | ||
Artisan International Small Cap Ins | 3.14B | 1.87 | -5.37 | - | ||
Oppenheimer International Small-MiI | 1.93B | -1.82 | -8.68 | 7.16 | ||
T. Rowe Price International Discov | 2.17B | 6.05 | -6.20 | 6.92 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
BAWAG | AT0000BAWAG2 | 1.94 | 73.450 | +0.14% | |
MercadoLibre | US58733R1023 | 1.63 | 2,005.00 | +1.87% | |
Spie | FR0012757854 | 1.43 | 30.54 | -0.65% | |
Keywords Studios PLC | GB00BBQ38507 | 1.36 | - | - | |
Redcare Pharmacy NV | NL0012044747 | 1.31 | 144.900 | +1.47% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review